The study of direct current neuromuscular electrical stimulation for peripheral neuropathy
NeuFit - Neurological Fitness and Education is recruiting patients for the clinical trial of Direct Current Neuromuscular Electrical Stimulation for Treatment of Peripheral Neuropathy.
This study will compare two methods of electrical stimulation (alternating current and direct current) as an adjunctive therapy to treating peripheral neuropathy. Both types of electrical stimulation have been used in clinical practice for physical therapy, however direct current stimulation is much less common and there is less known about their impact on physical therapy outcomes. The aim of this project is to show the efficacy of a novel device, the Neubie direct current device, compared to traditional TENS unit in clinical physical therapy treatment of neuropathy. Outcomes measured will include three methods of two-point discrimination, vibration sense, pain, and score on the modified Toronto Clinical Neuropathy scale.
Outcomes will be assessed by clinicians at Hands on Diagnostics locations. Assessors will be blinded to which intervention participant has received.
The researchers plan that July 1, 2022 will be the study start date. The indicative completion of the clinical trial will be expected in June 30, 2023.
There are a number of conditions that do not allow participation, such as:
- Currently pregnant - Cardiac pacemaker - Active or recent cancer in the lower limbs - Active or recent blood clots in the lower limbs - History of epilepsy - No open wounds.
The page dedicated to this clinical trial can be found here: https://ichgcp.net/clinical-trials-registry/NCT05442021 or https://clinicaltrials.gov/ct2/show/NCT05442021.
